-+ 0.00%
-+ 0.00%
-+ 0.00%

Sysmex to Present Alzheimer's Blood Biomarker Assay Validation Data at CTAD 2026

PUBT·11/09/2026 00:05:02
Sysmex to Present Alzheimer's Blood Biomarker Assay Validation Data at CTAD 2026
  • Sysmex will present Alzheimer's blood-based biomarker development data at the 19th Clinical Trials on Alzheimer's Disease conference in Boston, November 16-19, 2026.
  • The November 18 poster presentation will cover development and analytical validation of a high-sensitivity automated immunoassay for p-tau205.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sysmex Corporation published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.